Ro vs Zealthy
Zealthy has an open FDA warning letter dated September 9, 2025. Ro has none. No price lines up like for like: Ro and Zealthy publish prices for different products.
To see where both sit among the other sellers, read our best weight-loss injection providers board.
The record
Ro / Zealthy
Ro
7.4/10
Zealthy
5.6/10
Neither Ro nor Zealthy pays us. Links to them earn nothing. Scores: Ro 7.4, Zealthy 5.6. How we are paid
What the record shows
- 01
Zealthy has an open FDA warning letter dated September 9, 2025. Ro has none.
- 02
Zealthy names no compounding pharmacy in our record. Ro sells brand-name medication only.
- 03
No price lines up like for like: Ro and Zealthy publish prices for different products.
- 04
Only Ro lists a price for brand-name semaglutide pen, brand-name tirzepatide pen and brand-name semaglutide pill. Only Zealthy lists a price for compounded semaglutide injection and compounded tirzepatide injection.
Prices and terms, product by product
A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.
Ro
Zealthy
$286/mo
medication only, membership extra; not compared
$351/mo
medication only, membership extra; not compared
$199/mo
medication only, membership extra; not compared
$299/mo
medication only, membership extra; not compared
$149/mo
medication only, membership extra; not compared
$149/mo
medication only, membership extra; not compared
Read off each seller’s own pages. Ro: October 31, 2026. Zealthy: October 17, 2026. Every plan and dose we hold is on the full review.
The case for each
The case for Ro
7.4/10- No FDA warning letter on record
- Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Zealthy does not price
- Price leaves out medication
- Lowest price covers the medication only, with a separate membership on top
The case for Zealthy
5.6/10- Sells compounded semaglutide injection and compounded tirzepatide injection, which Ro does not price
- Open FDA warning letter, September 9, 2025
- Names no compounding pharmacy
- Lowest price covers the medication only, with a separate membership on top
Scores
Ro 7.4 · Zealthy 5.6 out of 10. Six weighted parts.
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
The score is the same formula for every seller. Payment does not enter it. Method
Ro vs Zealthy: questions
Other sellers we are paid by
Affiliate partners outside this pair. Each has its own record and review, scored the same way.
- bmiMD8.2
From $129/mo prepaid
Visit site - TrimRx6.4
From $299/mo
Visit site - Direct Meds7.1
From $249/mo
Visit site
Sellers closest to these two
Matched on molecule, form and price. Every pair we list · The register
Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks